Blockchain Registration Transaction Record

Gelrin C: A Game-Changer in Knee Cartilage Repair Economics

Regentis Biomaterials' Gelrin C is a cell-free hydrogel for knee cartilage repair, targeting a multi-billion-dollar market. Learn how this 10-minute procedure could reduce osteoarthritis costs.

Knee osteoarthritis affects millions, leading to pain, reduced mobility, and billions in healthcare costs. Gelrin C offers a cell-free, off-the-shelf solution that could halt cartilage damage progression, potentially avoiding costly joint replacements. For patients, it means a simpler, faster procedure; for the healthcare system, significant savings. This innovation matters because it addresses a critical gap in regenerative medicine, providing a practical and scalable treatment that could improve quality of life for countless individuals.